Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria
F. D’Amico(University of Padua), Umberto Cillo(University of Padua), Thomas D. Schiano(Icahn School of Medicine at Mount Sinai), Maria Guido(University of Padua), Alessandro Vitale(University of Padua), Swan N. Thung(Icahn School of Medicine at Mount Sinai), Juan Del Rio Martin(Mount Sinai Medical Center), Myron Schwartz(Icahn School of Medicine at Mount Sinai), Sasan Roayaie(White Plains Hospital), Parissa Tabrizian(Mount Sinai Hospital)
Cited by 116
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k